Timothy Liesching to Risk Assessment
This is a "connection" page, showing publications Timothy Liesching has written about Risk Assessment.
Connection Strength
0.127
-
Gazourian L, Regis SM, Pagura EJ, Price LL, Gawlik M, Lamb C, Rieger-Christ KM, Thedinger WB, Sanayei AM, Long WP, Stefanescu CF, Rizzo GS, Patel AS, Come CE, Thomson CC, Pinto-Plata V, Steiling K, McKee AB, Wald C, McKee BJ, Liesching TN. Qualitative coronary artery calcification scores and risk of all cause, COPD and pneumonia hospital admission in a large CT lung cancer screening cohort. Respir Med. 2021 09; 186:106540.
Score: 0.109
-
Come CE, Kramer MR, Dransfield MT, Abu-Hijleh M, Berkowitz D, Bezzi M, Bhatt SP, Boyd MB, Cases E, Chen AC, Cooper CB, Flandes J, Gildea T, Gotfried M, Hogarth DK, Kolandaivelu K, Leeds W, Liesching T, Marchetti N, Marquette C, Mularski RA, Pinto-Plata VM, Pritchett MA, Rafeq S, Rubio ER, Slebos DJ, Stratakos G, Sy A, Tsai LW, Wahidi M, Walsh J, Wells JM, Whitten PE, Yusen R, Zulueta JJ, Criner GJ, Washko GR. A randomised trial of lung sealant versus medical therapy for advanced emphysema. Eur Respir J. 2015 Sep; 46(3):651-62.
Score: 0.018